Lorcaserin: Difference between revisions

Jump to navigation Jump to search
(Created page with "ě{{CMG}} ==Overview== Lorcaserin is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 27 June 2012, the FDA...")
 
(#REDIRECT #REDIRECT #REDIRECT)
 
(31 intermediate revisions by 2 users not shown)
Line 1: Line 1:
ě{{CMG}}
#REDIRECT [[Lorcaserin Hydrochloride Hemihydrate]]
==Overview==
Lorcaserin is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic.  On 27 June 2012, the FDA officially approved lorcaserin for use in the treatment of obesity for adults with a BMI equal to or greater than 30 or adults with a BMI of 27 or greater who "have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol".
==References==
{{Reflist|2}}
 
{{WH}}
{{WS}}

Latest revision as of 21:29, 14 January 2015